BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16999662)

  • 1. Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.
    Patterson SL; LaMonte MP; Mikdashi JA; Haines ST; Hursting MJ
    Pharmacotherapy; 2006 Oct; 26(10):1518-25. PubMed ID: 16999662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful use of fondaparinux in a child with heparin-induced thrombocytopenia.
    Tokgoz H; Caliskan U; Demir M
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):769-71. PubMed ID: 22964766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute ischemic stroke successfully treated using sequenced intravenous and intra-arterial thrombolysis and argatroban anticoagulation: a case study.
    LaMonte MP; Stallmeyer MJ
    J Thromb Thrombolysis; 2004 Apr; 17(2):151-6. PubMed ID: 15306752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    Athar U; Husain J; Hudson J; Lynch J; Gajra A
    Am J Hematol; 2008 Mar; 83(3):245-6. PubMed ID: 17910040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1): a randomized, placebo-controlled safety study.
    LaMonte MP; Nash ML; Wang DZ; Woolfenden AR; Schultz J; Hursting MJ; Brown PM;
    Stroke; 2004 Jul; 35(7):1677-82. PubMed ID: 15155959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
    Ahmed S; Karim A; Patel D; Siddiqui R; Mattana J
    Am J Med Sci; 2002 Nov; 324(5):279-80. PubMed ID: 12449450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary antiphospholipid antibody syndrome and cerebral ischemia: report on acute intervention in two cases and literature review with emphasis on therapeutic options.
    Braune S; Siekmann R; Vaith P; Lücking CH
    Rheumatol Int; 1993; 13(4):169-74. PubMed ID: 8310211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
    LaMonte MP; Brown PM; Hursting MJ
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
    Huisman MV; Bounameaux H
    Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in acute ischemic stroke: A systematic search.
    Froio NL; Montgomery RM; David-Neto E; Aprahamian I
    Rev Assoc Med Bras (1992); 2017 Jan; 63(1):50-56. PubMed ID: 28225876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ictus and antiphospholipid syndrome: how much is enough?
    Rodríguez-Castellano E; Ríos-Blanco JJ; Robles-Marhuenda A; Gil-Aguado A; Soto-Abánades C; Pérez-Valero I; Royo-Orejas A; Vázquez-Rodríguez JJ
    Autoimmunity; 2008 Mar; 41(2):140-2. PubMed ID: 18324483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
    Thachil J
    Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban in thrombotic stroke.
    LaMonte MP
    Pathophysiol Haemost Thromb; 2002; 32 Suppl 3():39-45. PubMed ID: 12811011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke.
    Hosomi N; Naya T; Kohno M; Kobayashi S; Koziol JA;
    J Neurol; 2007 May; 254(5):605-12. PubMed ID: 17417744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin initiation and monitoring with clotting factors II, VII, and X.
    Trask AS; Gosselin RC; Diaz JA; Dager WE
    Ann Pharmacother; 2004 Feb; 38(2):251-6. PubMed ID: 14742761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin and other rapidly acting anticoagulants.
    Hyers TM
    Semin Vasc Surg; 2005 Sep; 18(3):130-3. PubMed ID: 16168887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary antiphospholipid syndrome presenting with cerebral ischemia, thrombocytopenia, anemia and proteinuria successfully treated with warfarin potassium.
    Miyata M; Sakata Y; Shibukawa G; Shishido H; Munakata O; Kazuta Y; Shio K; Sasajima T; Sato Y; Kasukawa R
    Intern Med; 2000 Sep; 39(9):748-53. PubMed ID: 10969908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.